DexCom, Inc. (DXCM)
69.54
+0.30
(+0.43%)
USD |
NASDAQ |
Jan 16, 16:00
69.20
-0.34
(-0.49%)
After-Hours: 20:00
DexCom Shareholders Equity (Annual): 2.103B for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Abbott Laboratories | 47.66B |
| BioLife Solutions, Inc. | 348.91M |
| Boston Scientific Corp. | 21.77B |
| Krystal Biotech, Inc. | 946.38M |
| Tandem Diabetes Care, Inc. | 263.10M |